ORCID: https://orcid.org/0000-0002-9566-8438; Unterrainer, Lena M.; Tiling, Maximilian; Mansour, Nabeel ORCID: https://orcid.org/0000-0002-3467-1916; Spitzweg, Christine ORCID: https://orcid.org/0000-0002-0413-9697; Brendel, Matthias ORCID: https://orcid.org/0000-0002-9247-2843; Ricke, Jens; Unterrainer, Marcus ORCID: https://orcid.org/0000-0002-8238-1198; Kunz, Wolfgang G. ORCID: https://orcid.org/0000-0002-5021-1952 und Mehrens, Dirk ORCID: https://orcid.org/0000-0001-5114-8935
(2025):
Cost-Effectiveness of [177Lu]Lu-DOTATATE for the Treatment of Newly Diagnosed Advanced Gastroenteropancreatic Neuroendocrine Tumors: An Analysis Based on Results of the NETTER-2 Trials.
In: Journal of Nuclear Medicine, Vol. 66, No. 7, jnumed.124.269416
[PDF, 865kB]
| Item Type: | Journal article |
|---|---|
| Faculties: | Medicine > Munich Cluster for Systems Neurology (SyNergy) Medicine > Medical Center of the University of Munich > Clinic and Polyclinic for Nuclear Medicine Medicine > Medical Center of the University of Munich > Clinic and Polyclinic for Radiology |
| Subjects: | 600 Technology > 610 Medicine and health |
| URN: | urn:nbn:de:bvb:19-epub-129544-8 |
| ISSN: | 0161-5505 |
| Language: | English |
| Item ID: | 129544 |
| Date Deposited: | 18. Nov 2025 10:25 |
| Last Modified: | 18. Nov 2025 10:25 |
| DFG: | Gefördert durch die Deutsche Forschungsgemeinschaft (DFG) - 390857198 |
Actions (login required)
- View Item
